NCT00034580View on ClinicalTrials.gov

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

August 31, 2002

Conditions
Bipolar Disorder
Interventions
DRUG

olanzapine

DRUG

risperidone

Trial Locations (21)

Unknown

Berkley

Los Angeles

Orange

San Marcos

Torrance

Denver

Middleton

Washington D.C.

Winter Park

Boise

Hoffman Estates

Natick

St Louis

Las Vegas

Clementon

Olean

Philadelphia

Madison

Houston

Richmond

Roanoke

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00034580 - Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder | Biotech Hunter | Biotech Hunter